🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an observational clinical study to evaluate the efficacy of the Cer...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-06-27
Trial ID
NCT07044024
Treatments Being Tested
The purpose of this randomized controlled trial is to investigate the effec...
Status
Completed
Location
Fudan University Shanghai Cancer Center
Start Date
2017-12-19
Trial ID
NCT03245346
The open, intra-individual study aims to assess the cutaneous acceptability...
Status
Completed
Location
Insight Research
Start Date
2021-01-13
Trial ID
NCT05490537
This is a multicenter, global, Phase 2, open-label, 2-part, first-line stud...
Status
Completed
Location
USC/Norris Comprehensive Cancer Center
Start Date
2019-08-29
Trial ID
NCT03929666
The purpose of this randomized controlled clinical trial is to investigate ...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2018-09
Trial ID
NCT03659292
The purpose of this study is to characterize the clinical effects of tislel...
Status
Recruiting
Location
Helios Clinical Research
Start Date
2026-04-30
Trial ID
NCT07554521
Treatments Being Tested
The ZANGEA trial is a open-label, single arm, multicenter phase II trial as...
Status
Recruiting
Location
Charité CVK
Start Date
2026-01-16
Trial ID
NCT07176312
Treatments Being Tested
This study will test a new personalized treatment approach for patients wit...
Status
Recruiting
Location
University of California, Los Angeles
Start Date
2026-07-20
Trial ID
NCT07290985
Treatments Being Tested
One of the problems faced by health services that deals with the diagnosis ...
Status
Completed
Location
IRCCS Burlo Garofolo
Start Date
2021-02-09
Trial ID
NCT05803278
Treatments Being Tested
In this study, the efficacy of botensilimab and balstilimab in mismatch rep...
Status
Recruiting
Location
The Netherlands Cancer Institute
Start Date
2024-01-29
Trial ID
NCT06279130
Treatments Being Tested